<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/1476-4598-2-20.anc" start="23667" end="23672" sStart="23605" offset="62" sid="r7.1.use.v.0151" wn="1" wnkey="use%2:34:01::" text="Total protein amount in the extracts was determined using the Bio-Rad Bradford reagent." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1476-4598-2-20.anc" start="13752" end="13756" sStart="null" offset="0" sid="null" wn="3" wnkey="time%1:28:00::" text="However, when the &lt;b&gt;time&lt;/b&gt; of TGF? treatment was reduced to 15 min or prolonged to 180 or 240 min, SB-203580 had a tremendous effect on Smad3 translocation to the nucleus." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-4598-2-20.anc" start="21479" end="21490" sStart="null" offset="123" sid="r11.recommend.v.0524" wn="1" wnkey="recommend%2:32:01::" text="TGF?1 was purchased from R&amp;D Systems and dissolved in 1 mg/ml bovine serum albumine in 4 mM HCl as recommended by the manufacturer." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1476-4598-2-20.anc" start="9056" end="9061" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="ets-1, ets-2 and ese-1/esx . Smad7 was of particular interest as it belongs to the inhibitory Smads, which can counteract TGF?-induced gene activation [ 23 ] . The response of the smad7 gene to TGF? is unusually &lt;b&gt;rapid&lt;/b&gt; [ 24 ] which is believed to stem from the peculiar nature of the Smad7 promoter that contains a &quot;perfect&quot; Smad binding site [ 25 ] . Another inhibitory Smad protein is Smad6." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1476-4598-2-20.anc" start="10678" end="10683" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="The &lt;b&gt;rapid&lt;/b&gt; induction of smad7 mRNA was basically unaffected by SB-203580; this could possibly explained by a lower amout of Smad3 necessary to activate the Smad7 promoter." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1476-4598-2-20.anc" start="9056" end="9061" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="ets-1, ets-2 and ese-1/esx . Smad7 was of particular interest as it belongs to the inhibitory Smads, which can counteract TGF?-induced gene activation [ 23 ] . The response of the smad7 gene to TGF? is unusually &lt;b&gt;rapid&lt;/b&gt; [ 24 ] which is believed to stem from the peculiar nature of the Smad7 promoter that contains a &quot;perfect&quot; Smad binding site [ 25 ] . Another inhibitory Smad protein is Smad6." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1476-4598-2-20.anc" start="6715" end="6720" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="Stimulation of the cells with TGF? led to a &lt;b&gt;rapid&lt;/b&gt; increase in nuclear Smad3 protein within 15 minutes and this level remained constant for 2 hours." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1476-4598-2-20.anc" start="10678" end="10683" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="The &lt;b&gt;rapid&lt;/b&gt; induction of smad7 mRNA was basically unaffected by SB-203580; this could possibly explained by a lower amout of Smad3 necessary to activate the Smad7 promoter." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-4598-2-20.anc" start="8845" end="8855" sStart="null" offset="52" sid="r10.particular.j.0225" wn="4" wnkey="particular%5:00:00:primary:00" text="ets-1, ets-2 and ese-1/esx . Smad7 was of particular interest as it belongs to the inhibitory Smads, which can counteract TGF?-induced gene activation [ 23 ] . The response of the smad7 gene to TGF? is unusually rapid [ 24 ] which is believed to stem from the peculiar nature of the Smad7 promoter that contains a &quot;perfect&quot; Smad binding site [ 25 ] . Another inhibitory Smad protein is Smad6." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-4598-2-20.anc" start="19122" end="19128" sStart="null" offset="43" sid="null" wn="2147483645" wnkey="null" text="However, TGF? downregulated Ese-1/Esx mRNA levels faster than it upregulated Smad7 expression excluding the possibility that Smad7 mediates the TGF? effect on Ese-1/Esx, at least at the initial phase." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-4598-2-20.anc" start="19122" end="19128" sStart="null" offset="43" sid="null" wn="1" wnkey="level%1:07:00::" text="However, TGF? downregulated Ese-1/Esx mRNA levels faster than it upregulated Smad7 expression excluding the possibility that Smad7 mediates the TGF? effect on Ese-1/Esx, at least at the initial phase." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-4598-2-20.anc" start="19122" end="19128" sStart="null" offset="43" sid="null" wn="1" wnkey="level%1:07:00::" text="However, TGF? downregulated Ese-1/Esx mRNA levels faster than it upregulated Smad7 expression excluding the possibility that Smad7 mediates the TGF? effect on Ese-1/Esx, at least at the initial phase." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-4598-2-20.anc" start="19122" end="19128" sStart="null" offset="43" sid="null" wn="1" wnkey="level%1:07:00::" text="However, TGF? downregulated Ese-1/Esx mRNA levels faster than it upregulated Smad7 expression excluding the possibility that Smad7 mediates the TGF? effect on Ese-1/Esx, at least at the initial phase." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-4598-2-20.anc" start="11412" end="11418" sStart="null" offset="64" sid="r9.level.n.0160" wn="2" wnkey="level%1:26:01::" text="We observed that ets1 and ets2 transcript levels were slightly upregulated when cells were incubated with TGF? and that this increase was partly inhibited by SB-203580." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-4598-2-20.anc" start="19122" end="19128" sStart="null" offset="43" sid="null" wn="" wnkey="null" text="However, TGF? downregulated Ese-1/Esx mRNA levels faster than it upregulated Smad7 expression excluding the possibility that Smad7 mediates the TGF? effect on Ese-1/Esx, at least at the initial phase." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-4598-2-20.anc" start="19122" end="19128" sStart="null" offset="43" sid="null" wn="2" wnkey="level%1:26:01::" text="However, TGF? downregulated Ese-1/Esx mRNA levels faster than it upregulated Smad7 expression excluding the possibility that Smad7 mediates the TGF? effect on Ese-1/Esx, at least at the initial phase." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-4598-2-20.anc" start="16396" end="16402" sStart="null" offset="19" sid="r8.family.n.0667" wn="3" wnkey="family%1:14:04::" text="Members of the Ets family of transcription factors share a unique DNA binding domain, the Ets domain, and have been shown to activate a large number of genes [ 42 43 ] and to be involved in a number of physiological and pathophysiological processes [ 44 ] . There has been accumulating evidence that Ets proteins play an important part for the invasive program of cells, particularly by stimulating the expression of protease genes [ 45 46 ] . Ets1 and Ets2 are overexpressed in a variety of tumors, including breast carcinomas ( [ 44 ] and references therein)." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-4598-2-20.anc" start="6411" end="6418" sStart="null" offset="98" sid="r11.absence.n.0397" wn="1" wnkey="absence%1:26:00::" text="Next, we studied the time-course of TGF?-induced Smad3 nuclear entry in the presence or absence of SB-203580." />
  </sentences>
</list>